Robot-guided surgery successfully drains multiple deep brain abscesses
Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through…
Insurance-supported integrative oncology symptom management program benefits cancer patients
A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program resulted in…
Six-gene signature predicts colorectal cancer recurrence after liver metastases
Researchers at The University of Texas MD Anderson Cancer Center identified a six-gene signature in microscopic colorectal cancer…
Could GLP-1 Drugs Reduce Breast Cancer Risk?
GLP-1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention. As reported by The…
Enhancing brain tumor detection through deep learning and explainable AI techniques
This section provides a comprehensive description of the proposed DL framework for brain tumor detection in MRI scans.…
Blood test may predict which colorectal cancer patients benefit from chemotherapy
A blood test may help identify which patients with colorectal cancer that has spread to the liver are…
Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific…
Targeted therapy doubles progression-free survival in rare bile duct cancer
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid…
Imaging scans detect prostate cancer progression despite stable PSA levels
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels…
City of Hope Develops Blood Test for Early Colorectal Cancer Detection
City of Hope is developing a blood test designed to detect colorectal cancer early, targeting a rising incidence…
Revolution Medicines to Present Clinical Data from RAS(ON)
REDWOOD CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, a late-stage clinical oncology company developing targeted…
Heart failure treatments protect heart function during cancer therapy
The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC…